Contract facts
FederalOND DRUG REVIEW & SCIENTIFIC REPORTING (EDITING AND WRITING) is a federal award for Fda Office Of Acq Grant Svcs held by Drt Strategies, Inc. Estimated value $3.6M ($3.6M obligated). Current period of performance ends Nov 30, 2022. Last award drew 1 bidder. Place of performance: SILVER SPRING MD.
OND DRUG REVIEW & SCIENTIFIC REPORTING (EDITING AND WRITING)
Recompete timing
PublicCurrent PoP ended Nov 30, 2022 (1360 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordDrt Strategies, Inc — $40.5M obligated across 37 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75F40122F80012?
75F40122F80012 (OND DRUG REVIEW scientific reporting (editing) is a Fda Office Of Acq Grant Svcs award with a potential value of $3.6M, currently held by Drt Strategies, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75F40122F80012?
Fda Office Of Acq Grant Svcs awarded 75F40122F80012 to Drt Strategies, Inc (potential $3.6M).
Who is the incumbent on 75F40122F80012?
Drt Strategies, Inc is the incumbent with $40.5M across 37 related awards in SCOUT’s public footprint. The current period of performance ends Nov 30, 2022.
When does Drt Strategies, Inc’s 75F40122F80012 come up for recompete?
SCOUT tracks a period-of-performance end of Nov 30, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
